UCB and Biogen say their first phase 3 trial of their systemic lupus erythematosus (SLE) candidate dapirolizumab pegol was a success, and a second is now expected to start before the end of the year.

Belgian biopharma company UCB is bringing up the rear of the IL-17 inhibitor category with its bimekizumab drug, so is celebrating new late-stage data showing superiority to the class leader.

Inflammatory Bowel Disease Treatment Market Size 2035 Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of th ...

The global Parkinson's disease drugs market size is projected to reach $10.4 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.

CBC Group, Singapore's largest healthcare company, has completed the acquisition of UCB's Chinese biopharmaceutical division in partnership with Mubadala Investment Company (UAE). This was reported in ...

The CalNet Directory Service contains records for current faculty, staff, and students at UC Berkeley. Notice: This campus directory is the property of the Regents of the University of California. In ...

United Community Banks, Inc. is a bank holding company, which engages in the provision of consumer and business banking services. The firm caters on individuals and small and medium-sized businesses.